Form 8-K - Current report:
SEC Accession No. 0001818331-26-000021
Filing Date
2026-03-02
Accepted
2026-03-02 07:02:39
Documents
14
Period of Report
2026-02-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K wgs-20260227.htm   iXBRL 8-K 31265
6 wgs-20260227_g1.jpg GRAPHIC 17936
  Complete submission text file 0001818331-26-000021.txt   247877

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT wgs-20260227.xsd EX-101.SCH 2256
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT wgs-20260227_def.xml EX-101.DEF 16936
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT wgs-20260227_lab.xml EX-101.LAB 29888
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT wgs-20260227_pre.xml EX-101.PRE 17783
16 EXTRACTED XBRL INSTANCE DOCUMENT wgs-20260227_htm.xml XML 4276
Mailing Address 333 LUDLOW STREET NORTH TOWER, 6TH FLOOR STAMFORD CT 06902
Business Address 333 LUDLOW STREET NORTH TOWER, 6TH FLOOR STAMFORD CT 06902 888-729-1206
GeneDx Holdings Corp. (Filer) CIK: 0001818331 (see all company filings)

EIN.: 851966622 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39482 | Film No.: 26703416
SIC: 8000 Services-Health Services
(CF Office: 08 Industrial Applications and Services)